Description
CJC-1295 Ipamorelin 5/5mg is a combination research compound consisting of CJC-1295 no DAC (a GHRH analog) and Ipamorelin (a ghrelin receptor analog), studied in preclinical research for their interactions with GHRH receptor and ghrelin receptor binding, and associated somatotropic signaling pathway analysis. Available exclusively for licensed research and laboratory use.
Research Background
This combination has been investigated in peer-reviewed studies examining pituitary signaling mechanisms involving somatotroph cell activation and ghrelin receptor binding. References are provided for informational purposes relating to published scientific literature.
Product Specifications
- Composition: CJC-1295 no DAC 5mg + Ipamorelin 5mg blend
- Purity: 99%+ verified by LCMS
- Format: Lyophilized powder
- Storage: -20°C, protected from light
For research use only. Not for human or animal consumption. Not a drug, food, or cosmetic. Must be handled by licensed, qualified professionals in a controlled laboratory setting.















